Secretion of cytokines in breast cancer cells: The molecular mechanism of procathepsin D proliferative effects

Journal of Interferon and Cytokine Research

Volumn 27, Issue 3, 2007, Pages 191-199

  Fusek, Martin ^a   Vetvickova, Jana ^b   Vetvicka, Vaclav ^b  

^a INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; CYTOKINE; ESTROGEN RECEPTOR; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PROCATHEPSIN D; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; AUTOCRINE EFFECT; BREAST CANCER; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG CANCER; MITOGENESIS; MOLECULAR MECHANICS; PARACRINE SIGNALING; PRIORITY JOURNAL; PROSTATE CANCER;

ANIMALS; AUTOCRINE COMMUNICATION; BREAST NEOPLASMS; CATHEPSIN D; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOKINES; ENZYME PRECURSORS; FEMALE; HUMANS; PARACRINE COMMUNICATION; RECEPTORS, ESTROGEN;

EID: 33947246508     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2006.0105     Document Type: Article

References (53)

1. Scadden DT. Cancer stem cells refined. Nat. Immunol. 2004; 5:701-703.
2. Jones RJ, Matsui WH, Smith BD. Cancer stem cells: are we missing the target? J. Natl. Cancer Inst. 2004;96:583-585.
3. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA, Daidone MG. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 2005;65:5506-5511.
4. Elenbaas B, Weinberg RA. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp. Cell Res. 2001;264:169-184.
5. Bissel MJ, Radisky D. Putting tumours in context. Nat. Rev. Cancer 2001;1:46-54.
6. Tlsty TD. Stromal cells can contribute oncogenic signals. Semin. Cancer Biol. 2001;11:97-104.
7. Cheng JD, Weiner LM. Tumors and their microenvironments: tilling the soil. Clin. Cancer Res. 2003;9:1590-1595.
8. Elenbaas B, Weinberg RA. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp. Cell Res. 2001;264:169-184.
9. Gache C, Berthois Y, Martin PN, Saez S. Positive regulation of normal and tumoral mammary epithelial cell proliferation by fibroblasts in coculture. In Vitro Cell. Dev. Biol. Anim. 1998;34: 347-351.
10. Dong-Le Bourhis X, Berthois Y, Millot G, Degeorges A, Sylvi M, Martin PM, Calvo F. Effect of stromal and epithelial cells derived from normal and tumorous breast tissue on the proliferation of human breast cancer cell lines in co-culture. Int. J. Cancer 1997;71: 42-48.
11. Brouty-Boye D, Raux H. Differential influence of stromal fibroblasts from different breast tissues on human breast tumour cell growth in nude mice. Anticancer Res. 1993;13:1087-1090.
12. van Roozendaal CE, van Ooijen B, Klijn JG, Claassen C, Eggermont AM, Henzen-Logmans SC, Foekens JA. Stromal influences on breast cancer cell growth. Br. J. Cancer 1992;65:77-81.
13. van Roozendaal KE, Klijn JG, van Ooijen B, Claassen C, Eggermont AM, Henzen-Logmans SC, Foekens JA. Differential regulation of breast tumor cell proliferation by stromal fibroblasts of various breast tissue sources. Int. J. Cancer 1996;65:120-125.
14. Hofland LJ, van der Burg B, van Eijck CH, Sprij DM, van Koetsveld PM, Lamberts SW. Role of tumor-derived fibroblasts in the growth of primary cultures of human breast-cancer cells: effects of epidermal growth factor and the somatostatin analogue octreotide. Int. J. Cancer 1995;60:93-99.
15. Brouty-Boye D, Mainguene C, Magnien V, Israel L, Beaupain R. Fibroblast-mediated differentiation in human breast carcinoma cells (MCF-7) grown as nodules in vitro. Int. J. Cancer 1994;56: 731-735.
16. 3 on growth of breast cancer cell lines. Breast Cancer Res. Treat. 1995;33:189-197.
17. Brooks B, Bundred NJ, Howell A, Lang SH, Testa NG. Investigation of mammary epithelial cell-bone marrow stroma interactions using primary human cell culture as a model of metastasis. Int. J. Cancer 1997;73:690-696.
18. Pourreyron C, Dumortier J, Ratineau C, Nejjari M, Beatrix O, Jacquier MF, Remy L, Chayvialle JA, Scoazec JY. Age-dependent variations of human and rat colon myofibroblasts in culture: influence of their functional interactions with colon cancer cells. Int. J. Cancer 2003;104:28-35.
19. Ronnov-Jessen L, Deurs BV, Celis JE, Petersen OW. Smooth muscle differentiation in cultured human breast gland stromal cells. Lab. Invest. 1990;63:532-543.
20. Ogmundsdottir HM, Petursdottir I, Gudmundsdottir I, Amundadottir L, Ronnov-Jessen L, Petersen OW. Effects of lymphocytes and fibroblasts on the growth of human mammary carcinoma cells studied in short-term primary cultures. In Vitro Cell Dev. Biol. Anim. 1993;29A:936-942.
21. Ronnov-Jessen L, Petersen OW, Koteliansky VE, Bissell MJ. The origin of the myofibroblasts in breast cancer. J. Clin. Invest. 1995;95:859-873.
22. Horgan K, Jones DL, Mansel RE. Mitogenicity of human fibroblasts in vivo for human breast cancer cells. Br. J. Surg. 1987;74: 227-229.
23. Mueller MM, Fusenig NE. Friends or foes: bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 2004;4:839-849.
24. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004;432:332-337.
25. Samoszuk M, Tan J, Chorn G. Clonogenic growth of human breast cancer cells co-cultured in direct contact with serum-activated fibroblasts. Breast Cancer Res. 2005;7:R274-R283.
26. Rochefort H, Garcia M, Glondu M, Laurent V, Liaudet E, Rey J, Roger P. Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview. Clin. Chim. Acta 2000;291:157-170.
27. Vetvicka V, Benes P, Fusek M. Procathepsin D in breast cancer: what do we know? Effects of ribozymes and other inhibitors. Cancer Gene Ther. 2002;9:854-863.
28. Leto G, Tumminello FM, Crescimanno M, Flandina C, Gebbia N. Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications. Clin. Exp. Metastases 2004; 21:91-106.
29. Vignon F, Capony F, Chambon M, Freiss G, Garcia M, Rochefort H. Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein. Endocrinology 1986;118: 1537-1545.
30. Stewart AJ, Piggott NH, May FEB, Westley BR. Mitogenic activity of procathepsin D purified from conditioned medium of breast-cancer cells by affinity chromatography on pepstatinyl agarose. Int. J. Cancer 1994;57:715-718.
31. Vetvicka V, Vetvickova J, Fusek M. Effect of human procathepsin D on proliferation of human cell lines. Cancer Lett. 1994;79: 131-135.
32. Vetvicka V, Vetvickova J, Hilgert I, Voburka Z, Fusek M. Analysis of the interaction of procathepsin D activation peptide with breast cancer cells. Int. J. Cancer 1997;73:403-409.
33. Fusek M, Vetvicka V. Mitogenic function of human procathepsin D-the role of the propeptide. Biochem. J. 1994;303:775-780.
34. Laurent-Matha V, Maruani-Herrman S, Prebois C, Beaujoin M, Glondu M, Noel A, Alvarez-Gonzales ML, Blacher S, Coopman P, Baghdiguian S, Gilles C, Lancarek J, Freiss G, Vignon F, Liaudet-Coopman E. Catalytically inactive human cathepsin D triggers fibroblast invasive growth. J. Cell Biol. 2005;168:489-499.
35. Berchem G, Glondu M, Gleizes M, Brouillet JP, Vignon F, Garcia M, Liaudet-Coopman E. Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis. Oncogene 2002;21:5951-5955.
36. Voburka Z, Vetvicka V, Vetvickova J, Fusek M. Cytokines affect procathepsin D-stimulated proliferation of breast cancer cells. Anticancer Res. 2002;22:913-919.
37. Haczynski J, Tarkowski R, Jarzabek K, Slomczynska M, Wolczynski S, Magoffin DA, Jakowicki JA, Jakimiuk AJ. Human cultured skin fibroblasts express estrogen receptor alpha and beta. Int. J. Mol. Med. 2002;10:149-153.
38. Lee HW, Eghbali-Webb M. Estrogen enhances proliferative capacity of cardiac fibroblasts by estrogen receptor- and mitogen-activated protein kinase-dependent pathways. J. Mol. Cell. Cardiol. 1998;30:1359-1368.
39. Mocellin S, Wang E, Marincola FM. Cytokines and immune response in the tumor microenvironment. J. Immunotherapy 2001; 24:392-407.
40. Prokopchuk O, Liu Y, Henne-Bruns D, Kornmann M. Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions. Br. J. Cancer 2005;92:921-928.
41. Blais Y, Gingras S, Haagensen DE, Labrie F, Simard J. Interleukin-4 and interleukin-13 inhibit estrogen-induced breast cancer cell proliferation and stimulate GCDFP-15 expression in human breast cancer cells. Mol Cell. Endocrinol. 1996;121:11-18.
42. Gooch JL, Lee AV, Yee D. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells. Cancer Res. 1998;58: 4199-4205.
43. Keping X. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev. 2001;12:375-391.
44. Brat DJ, Bellail AC, Van Meir EG. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro-Oncology 2005;7:122-133.
45. Xu L, Fidler IJ. Interleukin 8: an autocrine growth factor for human ovarian cancer. Oncol. Res. 2000;12:97-106.
46. Li A, Varney ML, Singh RK. Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials. Clin. Cancer Res. 2001;7:3298-3304.
47. Zhu YM, Webster SJ, Flower D, Woll PJ. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells. Br. J. Cancer 2004; 91:1970-1976.
48. Wang J, Huang M, Lee P, Komanduri K, Sharma S, Chen G, Dubinett SM. Interleuktn-8 inhibits non-small cell lung cancer proliferation: a possible role for regulation of tumor growth by autocrine and paracrine pathways. J. Interferon Cytokine Res. 1996;16: 53-60.
49. Moore KW, Waal Malefyt R, Coffman RL, O'Garra A. Interleukin 10 and interleukin 10 receptor. Annu. Rev. Immunol. 2001;19:683-765.
50. Vicari AP, Trinchieri G. Interleukin-10 in viral disease and cancer: exiting the labyrinth? Immunol. Rev. 2001;202:223-236.
51. Mocellin S, Marincola F, Rossi, CR, Nitti, D, Lise M. The multi-faced relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle. Cytokine Growth Factor Rev. 2004;15:61-76.
52. Moncellin S, Marincola, Young HA. Interleukin-10 and the immune response against cancer: a counterpoint. J. Leukocyte Biol. 2005;78:1043-1051.
53. + B-cells. Leuk. Lymphoma 1998;31:121-130.